1454675-21-8

Basic information

• Product Name: C₆₃H₇₀N₅O₁₂P
• Synonyms: C₆₃H₇₀N₅O₁₂P
• CAS NO: 1454675-21-8
• Molecular Weight: 1120.25
• Mol File: 1454675-21-8.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: C₆₃H₇₀N₅O₁₂P(CAS DataBase Reference)
• NIST Chemistry Reference: C₆₃H₇₀N₅O₁₂P(1454675-21-8)
• EPA Substance Registry System: C₆₃H₇₀N₅O₁₂P(1454675-21-8)

Safety Data

• Hazardous Substances Data: 1454675-21-8(Hazardous Substances Data)

Upstream product

• 1374576-19-8 C₁₂H₁₈O₆ 
• 1374576-20-1 (1S,3S,5S)-8-[(tert-butyldimethylsilyl)oxy]-7-(ethoxycarbonyl)methyl-5-hydroxy-3-methoxy-2-oxabicyclo[3.3.0]oct-7-ene 
• 1374576-23-4 (1S,2R,4R,6S,8S)-2-[(tert-butyldimethylsilyl)oxy]-4-(ethoxycarbonyl)methyl-6-hydroxy-8-methoxy-9-oxatricyclo-[4.3.0(1,6).0(2,4)]nonane 
• 1374576-25-6 (1S,2R,4S,6S)-2-[(tert-butyldimethylsilyl)oxy]-4-[(ethoxycarbonyl)methyl]-6-trimethylsilyloxy-9-oxatricyclo-[4.3.0(1,6).0(2,4)]non-7-ene 
• 1374576-26-7 1-[(3'R,5'R,6'S)-3'-O-trimethylsilyl-5'-O-(tert-butyldimethylsilyl)-6'-[(ethoxycarbonyl)methyl]-2'-deoxy-2'-iodo-3',5'-ethano-5',6'-methano-β-D-ribofuranosyl]thymine 
• 1374576-27-8 1-[(3'S,5'R,6'S)-3'-O-trimethylsilyl-5'-O-(tert-butyldimethylsilyl)-6'-[(ethoxycarbonyl)methyl]-2'-deoxy-3',5'-ethano-5',6'-methano-β-D-ribofuranosyl]thymine 
• 1454675-20-7 C₅₄H₅₃N₃O₁₁ 
• 124482-92-4 2-cyanoethyl-N,N-(diisopropylamino)chlorophosphine 
• 1374576-31-4 1-[(3'S,5'R,6'R)-5'-O-(tert-butyldimethylsilyl)-6'-(carboxymethyl)-2'-deoxy-3',5'-ethano-5',6'-methano-β-D-ribofuranosyl]thymine 
• 157887-82-6 9H-fluoren-9-ylmethyl N-(3-hydroxypropyl)carbamate 
• 1454675-18-3 C₃₉H₄₉N₃O₉Si 
• 1454675-19-4 C₃₃H₃₅N₃O₉ 
• 65-71-4 thymin 

Relevant articles and documents

TRICYCLIC NUCLEOSIDES AND OLIGOMERIC COMPOUNDS PREPARED THEREFROM

The present invention provides novel tricyclic nucleosides and oligomeric compounds prepared therefrom. Incorporation of one or more of the tricyclic nucleosides into an oligomeric compound is expected to enhance one or more properties of the oligomeric compound. Such oligomeric compounds can also be included in double stranded compositions. In certain embodiments, the oligomeric compounds provided herein are expected to hybridize to a portion of a target RNA resulting in loss of normal function of the target RNA.